Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Bioinformatics and Computational Biology
|
December 17, 2009
Dimension reduction of microarray gene expression data: the accelerated failure time model
Tuan S Nguyen, Javier Rojo
Statistical Applications in Genetics and Molecular Biology
|
February 19, 2009
Dimension reduction of microarray data in the presence of a censored survival response: a simulation study
Tuan S Nguyen, Javier Rojo
Leukemia & Lymphoma
|
November 5, 2013
A multicenter phase II study of single-agent enzastaurin in previously treated multiple myeloma
Eric Jourdan, Veronique Leblond, Hervé Maisonneuve, et al.
British Journal of Haematology
|
March 29, 2014
Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphoma
Lee Schwartzberg, Robert Hermann, Ian Flinn, et al.
Plos One
|
September 25, 2014
Association between gene expression profiles and clinical outcome of pemetrexed-based treatment in patients with advanced non-squamous non-small cell lung cancer: exploratory results from a phase II study
Dean A Fennell, Scott P Myrand, Tuan S Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2012
A multicenter phase II study of single-agent enzastaurin in previously treated Waldenstrom macroglobulinemia
Irene M Ghobrial, Philippe Moreau, Brianna Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2013
Randomized, phase II, placebo-controlled, double-blind study with and without enzastaurin in combination with paclitaxel and carboplatin as first-line treatment followed by maintenance treatment in advanced ovarian cancer
Ignace B Vergote, Radoslav Chekerov, Frederic Amant, et al.
American Journal of Translational Research
|
May 22, 2012
Biomarkers of the Hedgehog/Smoothened pathway in healthy volunteers
Sunil K Kadam, Bharvin K R Patel, Emma Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 2, 2015
Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy
William J Gradishar, Denise A Yardley, Rachel Layman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 1, 2013
Thymidylate synthase expression and outcome of patients receiving pemetrexed for advanced nonsquamous non-small-cell lung cancer in a prospective blinded assessment phase II clinical trial
Marianne C Nicolson, Dean A Fennell, David Ferry, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Bioinformatics and Computational Biology
|
December 17, 2009
Dimension reduction of microarray gene expression data: the accelerated failure time model
Tuan S Nguyen, Javier Rojo
Statistical Applications in Genetics and Molecular Biology
|
February 19, 2009
Dimension reduction of microarray data in the presence of a censored survival response: a simulation study
Tuan S Nguyen, Javier Rojo
Leukemia & Lymphoma
|
November 5, 2013
A multicenter phase II study of single-agent enzastaurin in previously treated multiple myeloma
Eric Jourdan, Veronique Leblond, Hervé Maisonneuve, et al.
British Journal of Haematology
|
March 29, 2014
Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphoma
Lee Schwartzberg, Robert Hermann, Ian Flinn, et al.
Plos One
|
September 25, 2014
Association between gene expression profiles and clinical outcome of pemetrexed-based treatment in patients with advanced non-squamous non-small cell lung cancer: exploratory results from a phase II study
Dean A Fennell, Scott P Myrand, Tuan S Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2012
A multicenter phase II study of single-agent enzastaurin in previously treated Waldenstrom macroglobulinemia
Irene M Ghobrial, Philippe Moreau, Brianna Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2013
Randomized, phase II, placebo-controlled, double-blind study with and without enzastaurin in combination with paclitaxel and carboplatin as first-line treatment followed by maintenance treatment in advanced ovarian cancer
Ignace B Vergote, Radoslav Chekerov, Frederic Amant, et al.
American Journal of Translational Research
|
May 22, 2012
Biomarkers of the Hedgehog/Smoothened pathway in healthy volunteers
Sunil K Kadam, Bharvin K R Patel, Emma Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 2, 2015
Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy
William J Gradishar, Denise A Yardley, Rachel Layman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 1, 2013
Thymidylate synthase expression and outcome of patients receiving pemetrexed for advanced nonsquamous non-small-cell lung cancer in a prospective blinded assessment phase II clinical trial
Marianne C Nicolson, Dean A Fennell, David Ferry, et al.
Page
of 2